Phase 1bInitiation

CMP-CPS-001

Urea Cycle Disorder

CAMPCAMP4 Therapeutics

Expected catalystTBA

Catalyst overview

Event details

Drug or asset: CMP-CPS-001
Development stage: Phase 1b
Event type: Initiation
Indication: Urea Cycle Disorder

Research summary

What is being tracked?

This catalyst tracks a Phase 1b initiation for CMP-CPS-001 in Urea Cycle Disorder. The expected timing is based on the latest available company guidance and may change.

Development notes

5/16/25- Study update reported. 8/14/25- Dosing completed in MAD cohort 3 and data from SAD and MAD cohorts in Q4 2025. 11/06/25:- Ph1 SAD/MAD trial safety/PK favorable; CTA cleared for Ph1b in OTC heterozygotes; seeking partner. 03/05/26:- PR No update. 05/07/26:- PR No update. 08/13/26:- PR No update.

Verification

Primary source

Confirm timing and program details against the company announcement or filing.

Source URL not provided